StockOtters
StockOttersSupply Chain Map
HLB Therapeutics Co.,Ltd. logo

HLB Therapeutics Co.,Ltd.

115450.KQ

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
41
Cost of Revenue
34
Gross Profit
8
Gross Margin
18.6%
Operating Income
-6
Operating Margin
-13.9%
Net Income
-17
Net Margin
-41.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-7
EBITDA Margin
-17.7%

2023

12/31/2023

Revenue
40
Cost of Revenue
35
Gross Profit
5
Gross Margin
12.5%
Operating Income
-7
Operating Margin
-16.2%
Net Income
-2
Net Margin
-4.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
5
EBITDA Margin
12.3%

2022

12/31/2022

Revenue
32
Cost of Revenue
26
Gross Profit
6
Gross Margin
18.9%
Operating Income
-6
Operating Margin
-17.7%
Net Income
-9
Net Margin
-26.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-4
EBITDA Margin
-11.2%

2021

12/31/2021

Revenue
33
Cost of Revenue
29
Gross Profit
3
Gross Margin
10.6%
Operating Income
-8
Operating Margin
-25.4%
Net Income
-13
Net Margin
-39.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-11
EBITDA Margin
-34.2%

2020

12/31/2020

Revenue
32
Cost of Revenue
28
Gross Profit
5
Gross Margin
14.2%
Operating Income
-8
Operating Margin
-26.2%
Net Income
-13
Net Margin
-39.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-9
EBITDA Margin
-26.9%